Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.

about

Review of vancomycin-induced renal toxicity: an update Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.

P2860

Q26746932-EB1557B8-1B68-4E95-9F63-DEC8692601FE Q38641774-6D909F42-8343-44F8-B839-43420D5F8F6B Q49980637-E980ECD2-2499-4C5B-84B4-49D72B7DD1C8

P2860

Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.

Item

http://www.wikidata.org/entity/Q41158049

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Vancomycin pharmacokinetics an ...... in pediatric cancer patients.

@en

type

Item

label

Vancomycin pharmacokinetics an ...... in pediatric cancer patients.

@en

prefLabel

Vancomycin pharmacokinetics an ...... in pediatric cancer patients.

@en

P1476

Vancomycin pharmacokinetics an ...... in pediatric cancer patients.

@en

P2093

Jennifer Le

http://www.w3.org/2001/XMLSchema#string

Lama H Nazer

http://www.w3.org/2001/XMLSchema#string

Ola Abdel Hadi

http://www.w3.org/2001/XMLSchema#string

Sawsan Mubarak

http://www.w3.org/2001/XMLSchema#string

Suha Al Omar

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center

Population clinical pharmacology of children: modelling covariate effects.

Improved vancomycin dosing in children using area under the curve exposure.

Emergence of MRSA in positive blood cultures from patients with febrile neutropenia--a cause for concern.

Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter

P304

448-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155215591386

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278731645

http://www.w3.org/2001/XMLSchema#string

P698

26079639

http://www.w3.org/2001/XMLSchema#string

Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.

about

P2860

P2860

Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698